Frontiers in Oncology | Hematologic Malignancies

Brief Research Report

Published on 05 Nov 2021

CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL)

in Hematologic Malignancies

Guido Gini
Alice Di Rocco
Luca Nassi
Annalisa Arcari
Maria Chiara Tisi
Giacomo Loseto
Attilio Olivieri
Massimo Gentile
Ombretta Annibali
Maria Giuseppina Cabras

Frontiers in Oncology

doi 10.3389/fonc.2021.730194

4,479 views

Original Research

Published on 04 Nov 2021

Comprehensive Analysis of m6A RNA Methylation Regulators in the Prognosis and Immune Microenvironment of Multiple Myeloma

in Hematologic Malignancies

Rui Liu
Ying Shen
Jinsong Hu
Xiaman Wang
Dong Wu
Meng Zhai
Ju Bai
Aili He

Frontiers in Oncology

doi 10.3389/fonc.2021.731957

5,653 views
9 citations

Original Research

Published on 04 Nov 2021

A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China

in Hematologic Malignancies

Weiping Liu
Donglu Zhao
Ting Liu
Ting Niu
Yongping Song
Wei Xu
Jie Jin
Qingqing Cai
Huiqiang Huang
Zhiming Li

Frontiers in Oncology

doi 10.3389/fonc.2021.750323

10,681 views
23 citations

Original Research

Published on 03 Nov 2021

Development and Validation of a Novel Prognostic Nomogram for CD5-Positive Diffuse Large B-Cell Lymphoma: A Retrospective Multicenter Study in China

in Hematologic Malignancies

Ziyuan Shen
Ling Wang
Bingpei Zhang
Tianci Li
Dashan Li
Chenlu He
Yuhao Xue
Ying Wang
Bingzong Li
Qinhua Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.754180

4,610 views
5 citations

Mini Review

Published on 03 Nov 2021

Distinctive Signaling Profiles With Distinct Biological and Clinical Implications in Aggressive CLL Subsets With Stereotyped B-Cell Receptor Immunoglobulin

in Hematologic Malignancies

Marina Gerousi
Stamatia Laidou
Katerina Gemenetzi
Kostas Stamatopoulos
Anastasia Chatzidimitriou

Frontiers in Oncology

doi 10.3389/fonc.2021.771454

5,912 views
15 citations

Brief Research Report

Published on 01 Nov 2021

Efficacy and Safety of Chimeric Antigen Receptor T Cells in Acute Lymphoblastic Leukemia With Post-Transplant Relapse

in Hematologic Malignancies

Lijuan Ding
Yiyun Wang
Ruimin Hong
Houli Zhao
Linghui Zhou
Guoqing Wei
Wenjun Wu
Huijun Xu
Yanlei Zhang
Yi Luo

Frontiers in Oncology

doi 10.3389/fonc.2021.750218

5,021 views
11 citations

Review

Published on 29 Oct 2021

Recent Progress in Interferon Therapy for Myeloid Malignancies

in Hematologic Malignancies

Fiona M. Healy
Lekh N. Dahal
Jack R.E. Jones
Yngvar Floisand
John F. Woolley

Frontiers in Oncology

doi 10.3389/fonc.2021.769628

10,230 views
17 citations

Review

Published on 29 Oct 2021

CCR7 in Blood Cancers – Review of Its Pathophysiological Roles and the Potential as a Therapeutic Target

in Hematologic Malignancies

Carlos Cuesta-Mateos
Fernando Terrón
Marco Herling

Frontiers in Oncology

doi 10.3389/fonc.2021.736758

9,915 views
23 citations

Original Research

Published on 28 Oct 2021

Elevated Lactate Dehydrogenase Levels Display a Poor Prognostic Factor for Non-Hodgkin’s Lymphoma in Intensive Care Unit: An Analysis of the MIMIC-III Database Combined With External Validation

in Hematologic Malignancies

Jiaqian Qi
Chengyuan Gu
Weijuan Wang
Mengqi Xiang
Xiaochen Chen
Jianhong Fu

Frontiers in Oncology

doi 10.3389/fonc.2021.753712

43,169 views
23 citations

Brief Research Report

Published on 28 Oct 2021

COVID-19 in Patients With Hematologic Malignancies: A Single Center Retrospective Study

in Hematologic Malignancies

Xuejun Alice Wang
Adam F. Binder
Usama Gergis
Lindsay Wilde

Frontiers in Oncology

doi 10.3389/fonc.2021.740320

3,366 views
8 citations

Review

Published on 28 Oct 2021

Treatment-Free Remission in Chronic Myeloid Leukemia and New Approaches by Targeting Leukemia Stem Cells

in Hematologic Malignancies

Yilin Chen
Jing Zou
Fanjun Cheng
Weiming Li

Frontiers in Oncology

doi 10.3389/fonc.2021.769730

9,901 views
26 citations

Review

Published on 28 Oct 2021

Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective

in Hematologic Malignancies

Ying-Jun Chang
Xiang-Yu Zhao
Xiao-Jun Huang

Frontiers in Oncology

doi 10.3389/fonc.2021.758512

15,865 views
18 citations

Clinical Trial

Published on 28 Oct 2021

Recombinant Human Thrombopoietin Accelerates the Recovery of Platelet in Patients With Lower-Risk Myelodysplastic Syndrome: A Proof-of-Concept Study

in Hematologic Malignancies

Yuan Yang
Zengwei Tang
Jiang Ji
Chen Yang
Miao Chen
Bing Han

Frontiers in Oncology

doi 10.3389/fonc.2021.721764

3,418 views
3 citations

Review

Published on 27 Oct 2021

Molecular Mechanisms of Ferroptosis and Its Roles in Hematologic Malignancies

in Hematologic Malignancies

Yan Zhao
Zineng Huang
Hongling Peng

Frontiers in Oncology

doi 10.3389/fonc.2021.743006

19,097 views
56 citations

Original Research

Published on 26 Oct 2021

The Hydropathy Index of the HCDR3 Region of the B-Cell Receptor Identifies Two Subgroups of IGHV-Mutated Chronic Lymphocytic Leukemia Patients With Distinct Outcome

in Hematologic Malignancies

Arancha Rodríguez-Caballero
Blanca Fuentes Herrero
Guillermo Oliva Ariza
Ignacio Criado
Miguel Alcoceba
Carlos Prieto
María Pérez Caro
Andrés C. García-Montero
Marcos González Díaz
Francesco Forconi

Frontiers in Oncology

doi 10.3389/fonc.2021.723722

4,424 views
1 citation

Brief Research Report

Published on 26 Oct 2021

Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms

in Hematologic Malignancies

Riccardo Moia
Micol Giulia Cittone
Paola Boggione
Giulia Francesca Manfredi
Chiara Favini
Bassel Awikeh
Anita Rebecca Pedrinelli
Abdurraouf Mokhtar Mahmoud
Maura Nicolosi
Mattia Bellan

Frontiers in Oncology

doi 10.3389/fonc.2021.777730

3,123 views
9 citations

Original Research

Published on 26 Oct 2021

A Murine Model With JAK2V617F Expression in Both Hematopoietic Cells and Vascular Endothelial Cells Recapitulates the Key Features of Human Myeloproliferative Neoplasm

in Hematologic Malignancies

Haotian Zhang
Amar Yeware
Sandy Lee
Huichun Zhan

Frontiers in Oncology

doi 10.3389/fonc.2021.753465

3,791 views
2 citations

Brief Research Report

Published on 26 Oct 2021

Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary Cells

in Hematologic Malignancies

Alain Chebly
Martina Prochazkova-Carlotti
Yamina Idrissi
Laurence Bresson-Bepoldin
Sandrine Poglio
Chantal Farra
Marie Beylot-Barry
Jean-Philippe Merlio
Roland Tomb
Edith Chevret

Frontiers in Oncology

doi 10.3389/fonc.2021.775253

3,191 views
4 citations

Original Research

Published on 25 Oct 2021

Prevalence of the GFI1-36N SNP in Multiple Myeloma Patients and Its Impact on the Prognosis

in Hematologic Malignancies

Cyrus Khandanpour
Christine Eisfeld
Subbaiah Chary Nimmagadda
Marc S. Raab
Niels Weinhold
Anja Seckinger
Dirk Hose
Anna Jauch
Asta Försti
Kari Hemminki

Frontiers in Oncology

doi 10.3389/fonc.2021.757664

5,229 views
4 citations

Perspective

Published on 22 Oct 2021

Intestinal Microbiome in Hematopoietic Stem Cell Transplantation For Autoimmune Diseases: Considerations and Perspectives on Behalf of Autoimmune Diseases Working Party (ADWP) of the EBMT

in Hematologic Malignancies

Tobias Alexander
John A. Snowden
Joachim Burman
Hyun-Dong Chang
Nicoletta Del Papa
Dominique Farge
James O. Lindsay
Florent Malard
Paolo A. Muraro
Rosamaria Nitti

Frontiers in Oncology

doi 10.3389/fonc.2021.722436

6,198 views
12 citations

Original Research

Published on 21 Oct 2021

LncRNA PPM1A-AS Regulate Tumor Development Through Multiple Signal Pathways in T-Cell Acute Lymphoblastic Leukemia

in Hematologic Malignancies

Guoli Li
Xinyue Lei
Yingchi Zhang
Zhe Liu
Kegan Zhu

Frontiers in Oncology

doi 10.3389/fonc.2021.761205

3,967 views
10 citations

Original Research

Published on 20 Oct 2021

LukS-PV Induces Apoptosis via the SET8-H4K20me1-PIK3CB Axis in Human Acute Myeloid Leukemia Cells

in Hematologic Malignancies

Liang Fei Xu
Lan Shi
Shan Shan Zhang
Peng Sheng Ding
Fan Ma
Kai Di Song
Ping Qiang
Wen Jiao Chang
Yuan Yuan Dai
Yi De Mei

Frontiers in Oncology

doi 10.3389/fonc.2021.718791

3,463 views
10 citations

Original Research

Published on 15 Oct 2021

Inhibition of Bromodomain and Extra Terminal (BET) Domain Activity Modulates the IL-23R/IL-17 Axis and Suppresses Acute Graft-Versus-Host Disease

in Hematologic Malignancies

Katiri J. Snyder
Hannah K. Choe
Yandi Gao
Natalie E. Sell
Kara M. Braunreiter
Nina C. Zitzer
Lotus Neidemire-Colley
Sonu Kalyan
Adrienne M. Dorrance
Andrea Keller

Frontiers in Oncology

doi 10.3389/fonc.2021.760789

6,870 views
16 citations

Original Research

Published on 14 Oct 2021

Protein Kinase CK1α Sustains B-Cell Receptor Signaling in Mantle Cell Lymphoma

in Hematologic Malignancies

Sabrina Manni
Anna Fregnani
Laura Quotti Tubi
Zaira Spinello
Marco Carraro
Greta Scapinello
Andrea Visentin
Gregorio Barilà
Marco Pizzi
Angelo Paolo Dei Tos

Frontiers in Oncology

doi 10.3389/fonc.2021.733848

5,938 views
5 citations

2,059 articles

articles

CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL)

Comprehensive Analysis of m6A RNA Methylation Regulators in the Prognosis and Immune Microenvironment of Multiple Myeloma

A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China

Development and Validation of a Novel Prognostic Nomogram for CD5-Positive Diffuse Large B-Cell Lymphoma: A Retrospective Multicenter Study in China

Distinctive Signaling Profiles With Distinct Biological and Clinical Implications in Aggressive CLL Subsets With Stereotyped B-Cell Receptor Immunoglobulin

Efficacy and Safety of Chimeric Antigen Receptor T Cells in Acute Lymphoblastic Leukemia With Post-Transplant Relapse

Recent Progress in Interferon Therapy for Myeloid Malignancies

CCR7 in Blood Cancers – Review of Its Pathophysiological Roles and the Potential as a Therapeutic Target

Elevated Lactate Dehydrogenase Levels Display a Poor Prognostic Factor for Non-Hodgkin’s Lymphoma in Intensive Care Unit: An Analysis of the MIMIC-III Database Combined With External Validation

COVID-19 in Patients With Hematologic Malignancies: A Single Center Retrospective Study

Treatment-Free Remission in Chronic Myeloid Leukemia and New Approaches by Targeting Leukemia Stem Cells

Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective

Recombinant Human Thrombopoietin Accelerates the Recovery of Platelet in Patients With Lower-Risk Myelodysplastic Syndrome: A Proof-of-Concept Study

Molecular Mechanisms of Ferroptosis and Its Roles in Hematologic Malignancies

The Hydropathy Index of the HCDR3 Region of the B-Cell Receptor Identifies Two Subgroups of IGHV-Mutated Chronic Lymphocytic Leukemia Patients With Distinct Outcome

Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms

A Murine Model With JAK2V617F Expression in Both Hematopoietic Cells and Vascular Endothelial Cells Recapitulates the Key Features of Human Myeloproliferative Neoplasm

Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary Cells

Prevalence of the GFI1-36N SNP in Multiple Myeloma Patients and Its Impact on the Prognosis

Intestinal Microbiome in Hematopoietic Stem Cell Transplantation For Autoimmune Diseases: Considerations and Perspectives on Behalf of Autoimmune Diseases Working Party (ADWP) of the EBMT

LncRNA PPM1A-AS Regulate Tumor Development Through Multiple Signal Pathways in T-Cell Acute Lymphoblastic Leukemia

LukS-PV Induces Apoptosis via the SET8-H4K20me1-PIK3CB Axis in Human Acute Myeloid Leukemia Cells

Inhibition of Bromodomain and Extra Terminal (BET) Domain Activity Modulates the IL-23R/IL-17 Axis and Suppresses Acute Graft-Versus-Host Disease

Protein Kinase CK1α Sustains B-Cell Receptor Signaling in Mantle Cell Lymphoma